Compounds > ciglitazone
Page last updated: 2024-10-25

ciglitazone and Barrett Epithelium

ciglitazone has been researched along with Barrett Epithelium in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konturek, PC1
Nikiforuk, A1
Kania, J1
Raithel, M1
Hahn, EG1
Mühldorfer, S1

Other Studies

1 other study available for ciglitazone and Barrett Epithelium

ArticleYear
Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors.
    Digestive diseases and sciences, 2004, Volume: 49, Issue:7-8

    Topics: Aged; Aged, 80 and over; Barrett Esophagus; Blotting, Western; Cyclooxygenase Inhibitors; Disease Pr

2004